Nausea and Vomiting: Evaluation and Management in Hospitalized Patients

Chapter 4
Nausea and Vomiting: Evaluation and Management in Hospitalized Patients


Katherine Aragon and Matthew J. Gonzales


Nausea is an unpleasant sensation that usually precedes vomiting. Nausea and vomiting are common in patients with serious illness, with almost three-quarters of patients admitted to a palliative care unit reporting it [1]. It is common in many end-stage diseases: 60% of advanced cancer patients, 43% of AIDS patients, 30% of end-stage renal disease patients, and 17% of heart failure patients [1, 2]. These symptoms are distressing for patients and families. Nausea and vomiting can lead to dehydration, electrolyte imbalances, and weight loss. Quick diagnosis and treatment can greatly improve these symptoms. In this chapter, we will detail a mechanism-based approach to the evaluation and management of nausea and vomiting.


4.1 PATHOPHYSIOLOGY


When exposed to a noxious stimulus, neuroreceptors activate one or more of the following four pathways: the cortex, the vestibular system, the chemoreceptor trigger zone (CTZ), or the receptors located in gastrointestinal (GI) tract. These pathways trigger the vomiting center located in the brain stem, which activates parasympathetic and motor-efferent nerves inducing vomiting [1, 3].


4.2 MANAGEMENT


While research in this area is limited, small studies have shown a mechanism-based approach, where the initial antiemetic agent is selected according to the most likely causative pathway, to be 80–90% effective in the palliative care population [4, 5]. An alternative strategy is an empiric approach starting with a dopamine antagonist regardless of the underlying etiology [6]. We prefer a mechanism-based approach as it allows for systematic workup and targeted management and minimizes polypharmacy. Table 4.1 summarizes this approach, which is described in detail later.


Table 4.1 Mechanism-Based Approach to Initial Management of Nausea and Vomiting







  1. Thorough evaluation: history and examination to narrow differential diagnosis
  2. Determine underlying pathway and associated neuroreceptor involved
  3. Choose antiemetic targeted against activated neuroreceptor
  4. Initiate IV antiemetic on an around-the-clock basis
  5. Titrate antiemetic to maximum recommended dose if symptoms not resolved
  6. Add an additional antiemetic aimed at a different neurotransmitter for persistent symptoms
  7. Evaluate for additional mechanisms that may be reversible and treat accordingly

4.2.1 Evaluation


A thorough history and examination is essential in elucidating the cause of nausea and/or vomiting. In over two-thirds of seriously ill patients, one or more causes will be determined [2]. History should focus on onset, frequency, and severity of nausea, recent medications, underlying medical illnesses, and associated symptoms. Ask about recent initiation or titration of opioids as commonly associated with nausea. Inquire about gastritis, reflux disease, and constipation as appropriate treatment may relieve symptoms. For cancer patients, find out the type of cancer, location of tumor(s), and any recent chemotherapy or radiotherapy. Key questions can help lead to determining the activated pathway. Early satiety, bloating, and relief of nausea with small-volume emesis are suggestive of gastric stasis. Alternatively, gastric obstruction is associated with colicky abdominal pain and large-volume bilious emesis. Nausea associated with certain smells or the sight of food suggests activation of the CTZ in the brain. Motion-induced nausea, often associated with vertigo indicates vestibular activation. Increased intracranial pressure typically causes early morning nausea and is associated with headaches and impaired cognition. Finally, anxiety or emotionally induced nausea suggests a cortical component [2, 7].


Physical examination should be attuned to confirming the pathway identified in the history. GI causes can be confirmed by evidence of ascites, enlarged liver, palpable abdominal mass, or impacted stool on rectal exam. Look for fever, confusion, asterixis, or neurological signs. Evidence of dehydration or weight loss may suggest symptom severity.


Laboratory tests may not be necessary on all patients with nausea and vomiting. A basic metabolic panel may show evidence of a reversible cause as detailed in Table 4.2 requiring appropriate medical management. A plain abdominal radiograph can help distinguish between constipation and obstruction. For patients near the end of life, it may be appropriate to treat symptomatically without additional laboratory or radiological testing depending on the goals of care.


Table 4.2 Reversible Causes of Nausea and Vomiting

























Causes Management


  • Hypercalcemia


  • IV fluids


  • Hyponatremia


  • Determine underlying cause and treat accordingly


  • Infection


  • Antibiotics


  • Constipation


  • Bowel regimen


  • Gastric irritation from anti-inflammatory medications


  • Stop anti-inflammatory; initiate PPI or H2 antagonist


  • Medications


  • Choose alternative agent

4.2.2 Treatment


According to a mechanism-based model, initial antiemetic should be effective against the most likely neuroreceptor involved. In the hospital setting, severe nausea and vomiting require initiation of an IV antiemetic. The chosen antiemetic should be prescribed around the clock and titrated to the maximum recommended dose until relief is achieved. If symptoms persist, add another agent directed against a different receptor [1, 3, 8]. Once nausea is controlled, transition patients to an oral formulation. Many patients will require antiemetics on discharge for chronic symptoms.


4.2.3 Alternative Treatments


Nonpharmacological approaches to nausea and vomiting may be of benefit in addition to antiemetics. For chemotherapy-induced nausea, acupuncture and acupressure are beneficial [9]. More feasible options in the hospital setting include small meals, carbonated drinks, and avoidance of strong odors [8].


4.3 APPROACH TO COMMON CAUSES


A small study of an inpatient palliative care unit found that the majority of nausea symptoms were caused by gastric stasis/outlet obstruction (35%) and chemical/metabolic disturbances (30%), primarily opioids [5]. A study of causes of nausea in hospice patients was similar: 44% were caused by impaired gastric emptying, 33% by chemical disturbance, and 19% by bowel obstruction [4]. In both studies, anxiety, increased intracranial pressure, and vestibular conditions made up only a few cases. Table 4.3 reviews common syndromes causing nausea/vomiting in seriously ill patients and their associated history and exam findings, specific causes, mechanism, and recommended treatment. These are detailed later (Table 4.4).


Table 4.3 Common Causes of Nausea/Vomiting in Seriously Ill Patients

























Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 14, 2016 | Posted by in EMERGENCY MEDICINE | Comments Off on Nausea and Vomiting: Evaluation and Management in Hospitalized Patients

Full access? Get Clinical Tree

Get Clinical Tree app for offline access
Clinical Syndrome History and Exam Findings Specific Causes Associated Pathway Antiemetics of Choice
Gastric stasis/impaired gastric emptying History

  • Early satiety
  • Postprandial fullness
  • Small-volume emesis
  • Nausea relieved by vomiting
Exam

  • Abdominal distension
  • Ascites


  • Abdominal malignancy
  • Ascites
  • Autonomic dysfunction
  • Malnutrition
  • Chemotherapy
  • Radiotherapy
  • Gastritis
  • Drugs (e.g., opioids)


  • Gastrointestinal stretch activating mechanoreceptors in the gut
  • Stimulation of D2 receptors in the gut


  1. Metoclopramide
  2. Haloperidol
  3. Prochlorperazine
Chemical/metabolic disturbances History

  • Persistent nauseas despite vomiting


  • Worsened by certain smells
Exam

  • Signs of infection


  • Signs of renal failure and liver failure


  • Hypercalcemia


  • Infection


  • Uremia


  • Chemotherapy


  • Drugs (e.g., opioids, antibiotics)


  • Activation of CTZ (D2, 5HT3 receptors)
  • Stimulation of D2 receptors in the gut
  • Stimulation of 5HT3 receptors in the gut


  1. Haloperidol
  2. Metoclopramide
  3. Prochlorperazine
Malignant bowel obstruction History

  • Colicky abdominal pain
  • Nausea relieved by vomiting
  • Bilious emesis
  • Constipation
Exam

  • Abdominal distension


  • Pain with palpation


  • Hyperactive bowel sounds